FNA Tumor Sampling for CD137 Modulation: A Pilot Study
Stopped early
Conditions studied: Head and Neck Cancer, Breast Cancer, Head and Neck Cancers, Non-Hodgkin Lymphoma, Colorectal Adenocarcinoma
In brief
The purpose of this study is to better understand the biology of the body's immune response to monoclonal antibody therapy for cancer. Your health information will be used to identify your tissues. The tissue we obtain may be useful for research or education, resulting in new drugs, therapies or diagnostic procedures.
Key facts
- Study ID
- NCT01114256
- Run by
- Stanford University
- People needed
- 83
- Starts
- 2010-03-01
- Expected to finish
- 2016-01-01
- Last updated by the study team
- 2017-08-03
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.